Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 102 | EYES2024

ESE Young Endocrinologists and Scientists (EYES) 2024

ea010230 | Diabetes, Obesity and Metabolism | EYES2024

Relation between autonomic symptoms and CAN risk score in type 2 diabetes: preliminary results

Stefano Boni , Eleonora Zanni , Silvia Coluccia , Massimiliano Colzani , Roberta Sueri , Vincenzo Rochira , Manuela Simoni , Carla Greco

Introduction: COMPASS 31 questionnaire is widely employed for screening of cardiac autonomic neuropathy (CAN) in diabetes, yet its diagnostic performance varies across studies. The aims of the study are to evaluate the relation between score of the COMPASS 31 and CAN Risk Score in type 2 diabetes (T2D); additionally, to assess its performance in diagnosing diabetic peripheral neuropathy (DPN).Methods: The study involved 68 participants with T2D (mean age...

ea010260 | Diabetes, Obesity and Metabolism | EYES2024

Liver fibrosis and peripheral neuropathy in type 2 diabetes: an observational cross-sectional study

Massimiliano Colzani , E1 Zanni , S Coluccia , S Boni , R Sueri , F Nascimbeni , M Simoni , C Greco

Background: Hepatic steatosis and diabetic peripheral neuropathy (DPN) share etiological and clinical correlates, while relationship between liver fibrosis and DPN has not been well investigated. AIMS. To evaluate the association between liver fibrosis and DPN and investigate the non-invasive scores of fibrosis as predictors of DPN.Methods: Observational, cross-sectional study including individuals with type 2 diabetes (T2D) and steatosis. Neurological a...

ea010221 | Diabetes, Obesity and Metabolism | EYES2024

Differential expression of miRNAs in type 1 diabetes patients: influence of age, diagnosis, body composition, and biochemical parameters

Victoria Garcia Ana , Villa-Fernandez Elsa , Garcia-Villarino Miguel , Cobo Alicia , Menendez-Torre Edelmiro , Ares Jessica , Pujante Pedro , Lambert Carmen

Introduction: Type 1 diabetes mellitus (T1DM) is an autoimmune disease primarily characterized by the destruction of pancreatic beta cells, leading to deficiencies in insulin production. The development of T1DM is attributed to a combination of environmental, immunological, metabolic, and epigenetic factors. The aim of this study is to analyze the expression profile of circulating miRNAs in T1DM patients to establish differences based on the time of diagnosis, whether in adult...

ea01028 | Diabetes, Obesity and Metabolism | EYES2024

Effects of semaglutide, peptide YY3-36 and empagliflozin on metabolic dysfunctionsassociated fatty steatotic liver disease in diet-induced obese rats with chronic nitric oxide synthase-inhibition

Geiger Niklas , Kloock Simon , Gerner Jana , Landthaler Aisha-Nike , Georg Nickel Alexander , Kohlhaas Michael , Maack Christoph , Geier Andreas , Fassnacht Martin , Dischinger Ulrich

Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common comorbidity of obesity. In this study, we sought to determine hepatic metabolic and mitochondrial effects of the Glucagon-like Peptide-1-agonist semaglutide, the sodium-glucose linked transporter 2-inhibitor empagliflozin and Peptide YY3-36 in diet-induced obese rats with additional chronic inhibition of nitric oxide synthase via Nω-nitro-L-arginine methyl ester (L-NAME), to induce ...

ea010217 | Diabetes, Obesity and Metabolism | EYES2024

The characteristics of 541 severe hypoglycaemia’s presentation and management underscore the need for improved services: pilot data from DEKODE hypoglycaemia study

Khatoon Aqeelah , Bal Aditya , Iqbal Ahmed , Ling Jie Yee Amanda , Page Charles , Persad Kalyaani , Idrissi Mariam , Ozturk Ozge , Kempegowda Punith , Sherratt Mayhew Sam

Introduction: Clinically significant hypoglycaemia, defined by blood glucose levels below 3 mmol/l (level 2) or requiring third-party assistance (level 3), poses significant risks for individuals with diabetes. However, limited information exists regarding their characteristics, management, and outcomes. The objective was to explore the characteristics, precipitating factors, and outcomes of individuals admitted with level 2 or 3 hypoglycaemia.Methods: T...

ea010296 | Diabetes, Obesity and Metabolism | EYES2024

Association between glycemic control parameters and diabetic macular edema in type 1 diabetes: a retrospective study using CGM data

Rita Leite Ana , Goncalves Juliana , Laiginhas Rita , Falcao Manuel , Queiros Joana , Sergio Neves Joao

Introduction: Diabetic macular edema (DME) is one of the leading causes of visual impairment in individuals with diabetes. In type 1 diabetes (T1D), DME is often a late-stage complication of diabetic retinopathy (DR). However, literature remains scarce regarding risk factors for DME, particularly its relationship with glycemic control assessed by continuous glucose monitoring (CGM). Methods: We conducted a retrospective cohort study of adult T1D patients...

ea010264 | Diabetes, Obesity and Metabolism | EYES2024

Long COVID is associated with accelerated aging in type 2 diabetes patients

Yerokhovych Viktoriia , Matviichuk Anton , Ilkiv Yeva , Krasnenkov Dmytro , Korcheva Veronika , Falalyeyeva Tetyana , Sulaieva Oksana , Komisarenko Iuliia , Kobyliak Nazarii

Background and aims: Leukocyte telomere length (LTL) is considered as a promising prognostic marker associated with COVID-19 severity, adverse outcomes (hospital admission, need for critical care, respiratory support), and mortality. However, LTL contribution to long COVID development is unclear. In this study, we aimed to evaluate the relationship between LTL and long COVID development in type 2 diabetes patients (T2D) concerning clinical phenotype, gender, and biological age...

ea010248 | Diabetes, Obesity and Metabolism | EYES2024

There is a need for better implementation of DKA guidelines - findings from the DEKODE DKA study

Chackalaparambil Philip Nevil , Ann Abraham Anu , Rengarajan Lakshmi , Kempegowda Punith

Introduction: In 2021, a new recommendation was put forward by the Joint British Diabetes Society-Inpatient (JBDS-IP) group to reduce fixed rate intravenous insulin infusion (FRIII) from 0.1 to 0.05 units/kg/hour when blood glucose falls <14 mmol/l in the management of Diabetic Ketoacidosis (DKA). This helped reduce the risk of associated complications. However, there has not been any evidence on whether this has been appropriately implemented. Metho...

ea0102137 | Diabetes, Obesity and Metabolism | EYES2024

Partial familial lipodistrophy - 2 case reports

Gidei Alexandra-Irina , Mohora Alexandra , Andrei Anca , Manole Andreea , Ungureanu Alicia , Dobre Ramona , Burcea Iulia-Florentina , Poiana Catalina

Introduction: Familial partial lipodistrophy (FPL) is a rare genetic disorder characterized by a progressive loss of adipose tissue from various areas of the body. Associated complications include diabetes mellitus, hypertriglyceridemia, non-alcoholic fatty liver disease, polycystic ovaries, acanthosis nigricans, premature atherosclerosis.Case presentation: The first case is about a 19-years-old woman, known with insulinoresistance (under metformin) and ...

ea010266 | Diabetes, Obesity and Metabolism | EYES2024

Low mitochondrial DNA is associated with post-COVID-19 syndrome in patients with type 2 diabetes

Ilkiv Yeva , Matviichuk Anton , Yerokhovych Viktoriia , Krasnenkov Dmytro , Korcheva Veronika , Falalyeyeva Tetyana , Botsun Pavlina , Sulaieva Oksana , Komisarenko Iuliia , Kobyliak Nazarii

Introduction: Post-COVID-19 syndrome (PCS; long COVID-19, post-acute COVID-19, long-term effects of COVID-19) is an emerging health problem in people recovering from COVID-19 infection within the past 3-6 months. The study of COVID-19 severity markers and the assessment of PCS prognosis have encouraged the discovery of the molecular mechanisms responsible for PCS and inevitable pathological conditions. Aim: to define the links between mitochondrial (mt)-DNA levels in blood leu...

ea010294 | Diabetes, Obesity and Metabolism | EYES2024

Normocytic anemia and its associated factors among type 2 diabetes mellitus

Gul Kose Hamidi Ece , Elveren Elif , Mirzaevi Elvar , Turkum Atikcan Simsek Deniz , Turhan İyidir Ozlem , Nar Aslı , Bascil Tutuncu Neslihan

Introduction: Anemia is one of the important complications of diabetes mellitus (DM), adversely affecting the progression and development of other diabetes-related complications. Despite this, little information is available on the prevalence of anemia and its associated factors in type 2 diabetes mellitus (T2DM). These associated factors are older age, worsening renal function, cardiovascular disease (stroke or ischemic heart disease), peripheral vascular disease, longer dura...

ea010213 | Diabetes, Obesity and Metabolism | EYES2024

Diabetic striatopathy in a patient with uncontrolled hyperglycemia: a rare case report

Shah Sanskruti , Barot Anuj

Introduction: Diabetic striatopathy (DS) is a rare and potentially fatal complication observed in individuals with uncontrolled hyperglycemia. Its prevalence, estimated at less than 1 in 100,000, underrepresents its true incidence, owing to the lack of knowledge about it in physicians. The highest prevalence was seen in Asia (71.6%), Europe (8.5%), and America (4%). Older Asian women were more affected, however, 6 cases were reported in pediatric patients.<p class="abstext...

ea010262 | Diabetes, Obesity and Metabolism | EYES2024

An animal model for heart failure with preserved ejection fraction (HFpEF)

Zytner Palina , Geiger Niklas , Federspiel Jan , Kloock Simon , Gerner Jana , Landthaler Aisha-Nike , Georg Nickel Alexander , Kohlhaas Michael , Maack Christoph , Geier Andreas , Fassnacht Martin , Dischinger Ulrich

Introduction: A strong association exists between obesity and heart failure with preserved ejection fraction (HFpEF). Obesity, usually induced by a high-fructose/high-fat Western diet, is one of the main causes of HFpEF. Here, we compare the cardiac and metabolic effects of different diets in combination with the NO-synthase inhibitor L-NAME (LN) in male Wistar rats. Methods: Male Wistar rats were randomized into the following groups (n = 6, all...